Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 24697-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MN1 antibody
- Antibody type
- Polyclonal
- Description
- MN1 antibody (Cat. #24697-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Characterization of cancer-related fibroblasts in bladder cancer and construction of CAFs-based bladder cancer classification: insights from single-cell and multi-omics analysis.
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosis.
Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer.
MN1 immunohistochemistry is a sensitive diagnostic biomarker for primitive CNS tumors with MN1 fusion.
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes.
Zhou Z, Chen Y, Wang Z, Yang S, Li Z, Shi R, Wang R, Liu K, Tang X, Li Q, Xu R
Frontiers in immunology 2025;16:1580986
Frontiers in immunology 2025;16:1580986
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosis.
Cai F, Xu S, Li Y, He Q, Su Q, Chen H, Liu W, Chen J, Wang Q, Assaraf YG, Lin Y, Zhuang W
Frontiers in immunology 2025;16:1554829
Frontiers in immunology 2025;16:1554829
Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer.
Wang Q, Weng S, Zhong W, Lin Y, Yu Y, Huang Y, Ge L, Zhang X, Xue F, Assaraf YG, Lin Y
Journal of translational medicine 2025 Jan 20;23(1):85
Journal of translational medicine 2025 Jan 20;23(1):85
MN1 immunohistochemistry is a sensitive diagnostic biomarker for primitive CNS tumors with MN1 fusion.
Daniel R, Tauziède-Espariat A, Métais A, Berthaud C, Pucelle N, Lacombe J, Collard A, Chrétien F, Varlet P
Acta neuropathologica 2024 Dec 2;148(1):77
Acta neuropathologica 2024 Dec 2;148(1):77
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB, Huang G, Tu J, Lv DM, Jin QL, Chen JK, Zou YT, Lee DF, Shen JN, Xie XB
EBioMedicine 2022 Aug;82:104142
EBioMedicine 2022 Aug;82:104142
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes.
Lehman NL, Spassky N, Sak M, Webb A, Zumbar CT, Usubalieva A, Alkhateeb KJ, McElroy JP, Maclean KH, Fadda P, Liu T, Gangalapudi V, Carver J, Abdullaev Z, Timmers C, Parker JR, Pierson CR, Mobley BC, Gokden M, Hattab EM, Parrett T, Cooke RX, Lehman TD, Costinean S, Parwani A, Williams BJ, Jensen RL, Aldape K, Mistry AM
Nature communications 2022 Apr 19;13(1):2083
Nature communications 2022 Apr 19;13(1):2083
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MN1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human MN1. This antibody recognizes human antigen. The MN1 antibody has been validated for the following applications: ELISA, IHC analysis.
